| ROK |
Report |
Adjusted EPS (FQ3'26) |
BEAT |
pred ~$3.46 vs. cons $3.38 |
MEDIUM |
| ROK |
Report |
Revenue (FQ3'26) |
IN-LINE |
pred ~$2.26B vs. cons $2.25B |
MEDIUM |
| ROK |
Report |
Enterprise operating margin (FQ3'26) |
IN-LINE |
pred ~22.0% vs. cons ~21.8% |
LOW |
| ROK |
Guide |
FY26 Adjusted EPS guide (midpoint) |
BETTER |
guide ~$12.95 (raise to $12.70-$13.20) vs. cons $12.85 (FY2026) |
MEDIUM |
| ROK |
Guide |
FY26 organic sales growth guide |
UNCHANGED |
guide ~7% (5%-9%) vs. cons ~7% (FY2026) |
MEDIUM |
| ROK |
Guide |
FY26 enterprise operating margin guide |
UNCHANGED |
guide ~21.5% vs. cons ~21.5% (FY2026) |
MEDIUM |
| ROK |
Guide |
Book-to-bill / order breadth (data center, semi, energy) |
BETTER |
guide ~1.0-1.05 vs. cons ~1.0 (FQ3'26) |
LOW |
| ROK |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| ROK |
Return |
5-day cumulative residual |
+0.5% (FADE) |
A ~5th straight beat plus a modest FY EPS raise (~$12.95 vs $12.85) should trigger an initial pop, but with the stock near all-time highs (~$481, +21% YTD, already gapped +15% on Q2) much of the broadening-demand/margin-upside story is priced in. Management pre-flagged sequentially lower H2 margins on a double-digit-million memory headwind, tariffs and higher project/E&D spend, so out-quarter (FQ4/FY27) estimate math gets trimmed even on a headline beat. That out-period drag plus profit-taking off a demanding valuation caps follow-through and pulls the initial residual gain roughly in half over five days. |
LOW |